Article
Outrage Over Dapagliflozin Withdrawal for Type 1 Diabetes in EU
Rating:
0.0
Views:
19
Likes:
1
Library:
1
The voluntary withdrawal of the type 1 diabetes indication for dapagliflozin in the EU by AstraZeneca has been branded as 'appalling' and 'devastating', with questions raised as to why it was pulled.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value